• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Mirati Therapeutics, Inc. - Common Stock (NQ: MRTX )

    N/A UNCHANGED
    Last Price Updated: 4:00 PM EST, Jan 22, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open -
    Bid (Size) 58.85 (1)
    Ask (Size) 59.74 (10)
    Prev. Close 58.70
    Today's Range N/A - N/A
    52wk Range 58.64 - 59.46
    Shares Outstanding 51,623,193
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024
    According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2023.  
    Via Benzinga
    EnerSys To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday
    Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
    Via Benzinga

    Performance

    More News

    Read More
    Analyst Expectations For Mirati Therapeutics's Future
    Via Benzinga
    Improving Survival Rates: Biotech Innovations in Pancreatic Cancer Treatment
    Via FinancialNewsMedia
    Topics Death
    Exposures Death
    What 11 Analyst Ratings Have To Say About Mirati Therapeutics
    Via Benzinga
    3 Resilient Stocks with Massive Potential to Boost Your Wealth
    Via InvestorPlace
    These Three Biotech Stocks Are Trading At A Discount
    Via Talk Markets
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    3 Biotech Stocks That Could Boom or Bust by 2025
    Via InvestorPlace
    MIRATI THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Mirati Therapeutics, Inc. - MRTX
    From Kahn Swick & Foti, LLC
    Via Business Wire
    3 No-Brainer Stocks to Buy With $500 Right Now
    Via The Motley Fool
    Appian To Rally Around 47%? Here Are 10 Top Analyst Forecasts For Tuesday
    Via Benzinga
    Is MIRATI THERAPEUTICS INC Ready to Break Out of Its Range?
    Via Chartmill
    7 Healthcare Stocks That Can Cure a Lackluster Portfolio
    Via InvestorPlace
    Opdivo's Subcutaneous Formulation Shows Promise in Advanced Kidney Cancer: Bristol Myers Squibb's Latest Findings
    Via Benzinga
    Bristol Myers Squibb Enters the Multi-Billion-Dollar Oncology Race
    Via PressReach
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Consolidated Communications Holdings, Inc. (Nasdaq – CNSL), Mirati Therapeutics, Inc.® (Nasdaq - MRTX), Pioneer Natural Resources (NYSE - PXD), Summit Materials (NYSE
    From Brodsky & Smith LLC
    Via GlobeNewswire
    Amgen Stock Surges To 10-Month High, Up 4% On An Unexpected Upgrade
    Via Investor's Business Daily
    Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2023
    Via Benzinga
    Elli Lilly Joins Big Pharma’s Multi-Billion-Dollar Oncology Race
    Via PressReach
    MIRATI THERAPEUTICS INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Mirati Therapeutics, Inc. - MRTX
    From Kahn Swick & Foti, LLC
    Via Business Wire
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    Why Shares of Tango Therapeutics Are Dropping Monday
    Via The Motley Fool
    Benzinga's Top Ratings Upgrades, Downgrades For October 9, 2023
    Via Benzinga
    Why ParaZero Technologies Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.